- Investing Ideas
- South Korean Pharmaceuticals & Biotech Sustainable Track Record
South Korean Pharmaceuticals & Biotech Sustainable Track Record
Results
7
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
7 companies
JW Holdings
Market Cap: ₩279.5b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩4,040.00
7D
-2.3%
1Y
22.1%
PharmaResearch
Market Cap: ₩4.3t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩416,000.00
7D
4.5%
1Y
-40.1%
JW Pharmaceutical
Market Cap: ₩630.1b
Manufactures and sells medicines and medical supplies in Japan and internationally.
A001060
₩27,600.00
7D
-4.3%
1Y
26.9%
Samsung BiologicsLtd
Market Cap: ₩72.7t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,573,000.00
7D
1.6%
1Y
-0.7%
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,250.00
7D
2.3%
1Y
15.2%
JW Shinyak
Market Cap: ₩112.0b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩2,005.00
7D
-4.5%
1Y
39.5%
SK Biopharmaceuticals
Market Cap: ₩6.8t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩86,400.00
7D
-1.0%
1Y
-14.0%